期刊文献+

晚期老年肺腺癌患者小剂量培美曲塞周疗一例报告 被引量:1

原文传递
导出
摘要 1病例报告 患者女,73岁。既往体健,无抽烟史,身高164cm,体质量40kg,体表面积1.44m22008—07—20患者无明显诱因出现咳嗽、左胸痛和消瘦,在外院行CT发现左上肺占位性病变(6cm×5cm).并经肺穿刺活检确诊为腺癌,ⅡA期(T2bN0M0)。患者拒绝手术,穿刺后行PC方案化疗,即紫杉醇,d1;卡铂,d1;每21d1个周期,2个周期后疗效评价SD。
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第5期383-384,共2页 Chinese Journal of Cancer Prevention and Treatment
基金 中国人民解放军空军总医院院内基金(kz2011020)
  • 相关文献

参考文献8

  • 1Weiss G J, Langer C,Rosell R,et al. Elderly patients benefil from second-line cytotoxic chemotherapy: a subset analysis of a ran- domized phasem trial of pemetrexed compared with docetaxel in tatients with previously treated advanced non small cell lung cancer[J]. J Clin 0nco1,2006,24(27) :4405-4411.
  • 2Maione P,Rossi A,Sacco PC, et al. Treating advanced non-small cell lung cancer in the elderly[J]. Ther Adv Med Oncol, 2010,2 (4) :251-260.
  • 3Wojas-Krawczyk K, Krawczyk P, Mlak R, et al. The applicability of a predictive index for second-and third-line treatment of unse- Ieeted non-small-cell lung cancer patients[J]. Respiration, 2011, 82(4) :341-350.
  • 4Gridelli C, Maione P,Rossi A, eta]. Treatment of advanced non- small ceil lung cancer in the elderly[J].Lung Cancer, 2009,66 (3):282-286.
  • 5Manegold C,Schmid-Bindert G, Pilz LR. Pemetrexed for the treatment of non-small cell lung cancer[J]. Expert Rev Amicancer Ther, 2009,9 (9) : 1195-1209.
  • 6韩金娣,方健,聂鋆,戴玲,王以尚,胡维亨,陈筱玲,田广明,韩森,王刚,高文斌,刘叙仪.培美曲塞治疗晚期肺腺癌的疗效观察[J].中华肿瘤防治杂志,2011,18(21):1722-1724. 被引量:13
  • 7李瑞超,郑丽君,邱红.国产培美曲塞二钠单药一线治疗老年晚期肺腺癌的近期疗效观察[J].中国医院药学杂志,2010,30(19):1668-1671. 被引量:3
  • 8韩云辉,韩强师,刘书东.培美曲塞二钠与多西紫杉醇单药治疗晚期非小细胞肺癌的对比研究[J].中华肿瘤防治杂志,2011,18(1):57-59. 被引量:26

二级参考文献17

  • 1张三海,赵绍宏.肺癌352例X线胸片及临床病理分析[J].解放军医药杂志,2010,22(S1):56-57. 被引量:1
  • 2Ohe Y. Chemoradiotherapy for lung cancer[J]. Expert Opin Pharma-cother,2005,6(16):2793-2804.
  • 3Adjei A A. Pemetrexed(ALIMTA), a novel multitargeted an-tineo-plastic agent [J]. Clin Cancer Res, 2004, 10 ( Suppl 12 ) :4276-4280.
  • 4Hanna N,Shephercl F A, Fossella F V, et al. Randomized phaseⅢ trial of pemetrexed verus docetaxel in patients with non-smallcell lung cancer previously treated with chemo therapy[J]. J Clin0ncol,2004,22(9) :1589-1597.
  • 5Hanna N, Shepherd F A, Fossella F V, et al. Randomized phase Ⅲtrial of pemetrexed verus docetaxel in patients with non-small celllung cancer previously treated with chemotherapy[J]. J Clin Oncol,2004,22(9):1589-1597.
  • 6Belani C P, Brodowicz T, Ciuleanu T, et al. Maintenance peme-trexed (Pem) plus best supportive care (BSC) versus placebo(Plac) plus BSC; A randomized phase [1I study in advanced non-small cell lung cancer(NSCLC)[J]. J Clin Oncol, E009,27 (18S):CRA8000.
  • 7Dickgreber N J, Sorensen J B, Paz-Ares L G, et al. Pemetrexed safety and pharmacokinetics in patients with third space fluid clin [J]. CancerRes,2010,16(10):2872-2880.
  • 8Gronberg B H,Bremnes R M,Flotten O,et al. Phase Ⅲ study by the norwegian lung cancer study group; pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer[J]. J Clin 0ncol,2009,27(19) :3217-3224.
  • 9李龙芸,汪斌超.老年或功能状态评分差的晚期非小细胞肺癌患者一线化疗的Ⅱ期临床试验:培美曲塞单药与培美曲塞/吉西他滨序贯化疗的比较[J].循证医学,2007,7(5):263-266. 被引量:32
  • 10曹卡加,吴一龙,刘奕龙,马国胜,邓芳.广州市2000-2002年肺癌发病率与死亡率分析[J].中国肿瘤,2008,17(4):281-283. 被引量:20

共引文献38

同被引文献24

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部